These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 16125245)
21. Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration. Ramírez-Camacho R; Fernández DE; Verdaguer JM; Gómez MM; Trinidad A; García-Berrocal JR; Corvillo MA Acta Otolaryngol; 2008 May; 128(5):505-9. PubMed ID: 18421602 [TBL] [Abstract][Full Text] [Related]
22. Cisplatin induces cytoplasmic to nuclear translocation of nucleotide excision repair factors among spiral ganglion neurons. Guthrie OW; Li-Korotky HS; Durrant JD; Balaban C Hear Res; 2008 May; 239(1-2):79-91. PubMed ID: 18329831 [TBL] [Abstract][Full Text] [Related]
23. Effect of chronic estradiol administration on vimentin and GFAP immunohistochemistry within the inner ear. Horner KC; Troadec JD; Dallaporta M; Pio J Neurobiol Dis; 2009 Aug; 35(2):201-8. PubMed ID: 19410647 [TBL] [Abstract][Full Text] [Related]
24. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750 [TBL] [Abstract][Full Text] [Related]
25. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition. Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286 [TBL] [Abstract][Full Text] [Related]
26. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig. Ekborn A; Lindberg A; Laurell G; Wallin I; Eksborg S; Ehrsson H Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204 [TBL] [Abstract][Full Text] [Related]
27. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Lee KW; Jeong JY; Lim BJ; Chang YK; Lee SJ; Na KR; Shin YT; Choi DE Toxicology; 2009 Mar; 257(3):137-43. PubMed ID: 19152827 [TBL] [Abstract][Full Text] [Related]
28. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect. Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384 [TBL] [Abstract][Full Text] [Related]
29. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229 [TBL] [Abstract][Full Text] [Related]
33. [Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics]. Lautermann J; Dehne N; Schacht J; Jahnke K Laryngorhinootologie; 2004 May; 83(5):317-23. PubMed ID: 15143449 [TBL] [Abstract][Full Text] [Related]
34. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs. Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519 [TBL] [Abstract][Full Text] [Related]
35. Endogenous protection against oxidative stress caused by cisplatin: role of superoxide dismutase. González-García JA; Nevado J; García-Berrocal JR; Sánchez-Rodríguez C; Trinidad A; Sanz R; Ramírez-Camacho R Acta Otolaryngol; 2010 Apr; 130(4):453-7. PubMed ID: 19883181 [TBL] [Abstract][Full Text] [Related]
36. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Li G; Frenz DA; Brahmblatt S; Feghali JG; Ruben RJ; Berggren D; Arezzo J; Van De Water TR Neurotoxicology; 2001 Apr; 22(2):163-76. PubMed ID: 11405249 [TBL] [Abstract][Full Text] [Related]
37. L- and D- methionine provide equivalent long term protection against CDDP-induced ototoxicity in vivo, with partial in vitro and in vivo retention of antineoplastic activity. Reser D; Rho M; Dewan D; Herbst L; Li G; Stupak H; Zur K; Romaine J; Frenz D; Goldbloom L; Kopke R; Arezzo J; Van De Water T Neurotoxicology; 1999 Oct; 20(5):731-48. PubMed ID: 10591510 [TBL] [Abstract][Full Text] [Related]
38. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Ilbey YO; Ozbek E; Cekmen M; Simsek A; Otunctemur A; Somay A Hum Reprod; 2009 Jul; 24(7):1717-25. PubMed ID: 19279034 [TBL] [Abstract][Full Text] [Related]
39. Cisplatin Toxicology: The Role of Pro-inflammatory Cytokines and GABA Transporters in Cochlear Spiral Ganglion. Gao D; Yu H; Li B; Chen L; Li X; Gu W Curr Pharm Des; 2019; 25(45):4820-4826. PubMed ID: 31692421 [TBL] [Abstract][Full Text] [Related]
40. Recovery of hearing following cisplatin ototoxicity in the guinea pig. O'Leary SJ; Klis SF Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]